Aram Hong

Aram Hong is the CEO and co-founder of Apollon, a Seoul-born, Cambridge-based medtech company building MOGLU, a needle-free continuous glucose monitor powered by Raman spectroscopy. A former EY advisor and Genoplan executive who moved his family from Seoul to Boston to scale the company alongside MIT researchers, Hong has turned a laser-and-optics idea into a CES 2025 Innovation Award honoree that, in peer-reviewed clinical testing, matched the accuracy of leading needle-based sensors from Abbott and Dexcom.